Cambrex Corporation

(CBM) Trade

By |

Profile

Cambrex Corp is a biotechnology company focused on developing and commercializing new and generic therapeutics. It provides products and services that accelerate and improve the development and commercialization of new and generic therapeutics.

Contact Information

Website: www.cambrex.com
Email: stephanie.lafiura@cambrex.com
Main Phone: +1 201 804-3000
Address: One Meadowlands Plaza
State: NJ
City / Town: East Rutherford
Country: USA
Postal Code: 07073

Issuer Information

Exchange: NYE
CEO: Steven M. Klosk
Employees: 1228
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)
$ 62.48 $ 0.28 (0.44%)
Last Price 62.48 Change $ 0.28 Change % 0.44 Tick N/A
Bid 62.45 Bid Size 100.00 Ask 62.55 Ask Size 100.00
Open 62.35 High 63.35 Low 62.20 Prev Close 62.20
Last Trade Volume 101,462 52 Wk Hi 67.85 52 Wk Low 42.55
Market Cap 2.1 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 33,258,256.00 EPS (TTM) 3.64 PE Ratio 17.10 Exchange NYSE
  Last 3 Mo Last 12 Mo
Number of Insider Trades 20 35
Number of Buys 14 23
Number of Sells 6 12
Net Activity 9779 30700
Last 10 Buys Shares
Louis J. Grabowsky 1,000
James Francis Winschel 1,000
Ilan Kaufthal 1,000
Ilan Kaufthal 1,000
Ilan Kaufthal 1,000
Rosina B. Dixon 1,000
Rosina B. Dixon 1,000
Ilan Kaufthal 1,000
Last 10 Sell Shares
Steven M. Klosk 1,000
Gregory P. Sargen 1,000
Gregory P. Sargen 1,000
Shawn Cavanagh 1,000
Gregory P. Sargen 1,000
Shawn Cavanagh 1,000
Steven M. Klosk 1,000
Steven M. Klosk 1,000
Steven M. Klosk 1,000
Steven M. Klosk 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 61 61 61 61
Low Target Price Estimate 60 60 60 60
Mean Target Price Estimate 60.5 60.5 60.5 60.5
Standard Deviation 0.71 0.71 0.71 0.71
Date of Most Recent Estimate 06/04/18 02/28/18 02/28/18 06/04/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 4 4 4 4
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.4 1.4 1.4 1.4